Candidate biomarkers for fatigue in systemic lupus erythematosus: A critical review

Mary A. Mahieu*, Rosalind Ramsey-Goldman

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Fatigue impacts 80-90% of patients with systemic lupus erythematosus (SLE), and an incomplete understanding of fatigue mechanisms limits effective treatment. Disease activity indices and laboratory markers inconsistently correlate with fatigue severity in SLE populations. Identification of fatigue biomarkers has important implications for understanding pathogenesis and defining novel therapeutic targets, but a paucity of evidence exists for fatigue biomarkers in SLE. The evidence for adipokines, reduced glutathione, iron deficiency, and vitamin D as potential biomarkers for SLE-related fatigue are reviewed. To address gaps in the SLE literature, the experience of each fatigue biomarker in other diseases is examined. Finally, biomarker associations with SLE pathogenesis and disease activity are discussed, as further rationale for investigation among SLE patients.

Original languageEnglish (US)
Pages (from-to)103-112
Number of pages10
JournalCurrent Rheumatology Reviews
Issue number2
StatePublished - Aug 1 2017


  • Adipokines
  • Biomarkers
  • Fatigue
  • Glutathione
  • Iron deficiency
  • Systemic lupus erythematosus
  • Vitamin D

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Candidate biomarkers for fatigue in systemic lupus erythematosus: A critical review'. Together they form a unique fingerprint.

Cite this